Investment - Investment Event Series
AusBiotech Investment Event Series
The AusBiotech Investment Event Series comprises of state-based, national and international investor events to showcase Australian life sciences companies to potential partners and investors. These events connect life science investors with biotech and medtech innovators from across the globe to discuss investment and partnership opportunities. Events are held in key locations around the world.
- Access investment opportunities
Global capital market access is essential for life science companies, who typically face a long time to market. AusBiotech’s Investment Event Series directly connects innovative companies with the investment community, enabling Australian life science companies to present their business case in an eight-minute to a room full of investors and offering networking opportunities.
- Inform your investment dollar
AusBiotech’s Investment Event Series assembles a well-researched, high-quality program to deliver crucial information to life science investors. Speakers include local and international experts who are at the forefront of investing and partnering.
- Form partnerships and strengthen connections
AusPartnering, AusBiotech’s business matching program, helps delegates arrange one-on-one meetings to streamline during selected events. Various networking events across the Investment Event Series form a key component of AusBiotech’s events to foster spontaneous opportunities and broaden connections in the life sciences.
Biotech Showcase Conference
The ninth annual Biotech Showcase Conference will be held in San Francisco from 9-11 January 2017. AusBiotech will lead the Australian delegation to the event, which provides biotech investors and companies with networking opportunities over three days.
Investment Series Asia March 2017
AusBiotech’s Investment Event Series will visit Singapore, Hong Kong and for the first time Shanghai (details forthcoming) in March 2017. Each event will feature company presentations from innovative companies, panel discussions tackling key issues and keynote presentation delivered by investment experts. There will be opportunities for companies to arrange meetings with investors and potential partners and attend networking events.
Australia Biotech Invest 2017, 22 - 23 October 2017, Melbourne
Australia Biotech Invest will run over two days in Melbourne in 2017. Panel discussions and keynote presentations will provide critical insight into investment trends, and over 25 company presentations from Australian and international biotech and medtech companies will present their business case.
Be part of the program
AusBiotech is currently welcoming expressions of interest for company presentations, speakers and partners. Contact firstname.lastname@example.org or +61 3 9828 1435.
A consortium led by AusBiotech has received funding from the Medical Technologies and Pharmaceuticals Industry Growth Centre (MTPConnect) for a comprehensive global investment education program for the Australian life sciences sector, which will cater to the needs of companies, investors and researchers.
Major outcomes of the project include:
- Education, resources and training for companies and potential university and research institute spin outs
- Education and resources for investors
- Access to global capital markets for Australian life science companies
Asia Biotech Invest 2016 5-6 May 2016, Hong Kong Convention & Exhibition Centre
Singapore Biotech Invest 2016 3 May 2016, Singapore Exchange, Singapore
Australia Biotech Invest 2015 6-7 October 2015, Melbourne
Asia Biotech Invest 2015, Hong Kong, 19 - 21 May 2015
Asia Biotech Invest, June 2014, the the largest-ever biotech showcase to be held in Hong Kong, attracting more than 240 high-level delegates from across the life science community.
Australia Biotech Invest 2014 – Connecting Capital with Innovation, 3 – 4 December 2014, Melbourne
- Special edition of Ahead of the Curve, 'Future Proof: The investment case for biotech'
- View the post-event Report and a Summary of the discussions.
- Events were held in Perth, Brisbane and Adelaide. The format provided listed and IPO-ready companies opportunities to present to a captive audience of brokers and investors, followed by networking drinks.
Australian Life Science Investment Showcase, 20 June 2014, Sir Francis Drake Hotel, San Francisco, USA
Denver Business Networking Event, 18 June 2014
Asia Biotech Invest - Connecting Capital with Innovation, 4 – 5 June 2014, Sheraton Hong Kong Hotel & Towers, Hong Kong
Australia Biotech Invest 2013 – Connecting Capital with Innovation, 28 – 29 October 2013, Melbourne Convention Centre, Melbourne, Australia
Asia Biotech Invest - Connecting Capital with Innovation, 3 – 5 June 2013, Sheraton Hong Kong Hotel & Towers, Hong Kong
Australian Life Science Investment Showcase: New York, Ernst & Young Corporate Headquarters, 5 Times Square, New York, USA
Cowen's 2013 Asia Pacific Life Science Showcase, 7 January 2013 (annexed to JP Morgan Healthcare conference), Sir Francis Drake Hotel, San Francisco, USA
Australasian Life Science Investment Summit 2012, 2 November (part of the AusBiotech 2012 conference), Melbourne Convention & Exhibition Centre, Melbourne, Victoria
Emerging Company Showcase (with Wholesale Investor), 22 November 2012, PricewaterhouseCoopers offices, Freshwater Place, Level 19, 2 Southbank Blvd, Melbourne
Capital Showcase Sydney 2012 (with Wholesale Investor), 17 September 2012, PwC Offices, Darling Park Tower 2, Level 10, 201 Sussex Street, Sydney.